Clinical Trial Update: ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation [Phase 3]

View source ↗

Summary

Phase 3 trial of irbesartan in patients with acute coronary syndrome without ST-segment elevation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Hypertension
• Myocardial Ischemia

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Myocardial Ischemia, Hypertension | Phase 3 | Status: COMPLETED